Sangamo Therapeutics, Inc. is a genomic medicine company. The Company’s zinc finger (ZF) epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid engineering platform has demonstrated the ability to expand delivery beyond available intrathecal delivery capsids, including in the central nervous system (CNS), in preclinical studies. Zinc finger technologies are derived from naturally occurring human proteins. They are composed of a DNA-binding domain, which binds with precision to any sequence of DNA, and various functional domains (such as nucleases and transcription factors) based on therapeutic needs. Its pipeline includes Chronic Neuropathic Pain - ST-503 and Isaralgagene civaparvovec (ST-920). ST-503 is an investigational epigenetic regulator for the treatment of intractable pain due to iSFN, a type of chronic neuropathic pain. ST-920 is a wholly owned gene therapy product candidate for the treatment of Fabry disease.
What is the share price of Sangamo Therapeutics, Inc. today?
Sangamo Therapeutics, Inc. (SGMO) share price as of March 18, 2026 is $0.38. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Sangamo Therapeutics, Inc.?
Yes, Indian Investors can invest in the Sangamo Therapeutics, Inc. (SGMO) Share by opening an international trading account with Angel One.
How can I purchase Sangamo Therapeutics, Inc. shares in India?
Purchasing Sangamo Therapeutics, Inc. (SGMO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Sangamo Therapeutics, Inc. (SGMO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Sangamo Therapeutics, Inc.?
Yes, you can purchase fractional shares of Sangamo Therapeutics, Inc. (SGMO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Sangamo Therapeutics, Inc.?
The market capitalization of Sangamo Therapeutics, Inc. on February 11, 2026, is $141.24 M.
In which sector Sangamo Therapeutics, Inc. belongs?
Sangamo Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.
What documents are required to invest in Sangamo Therapeutics, Inc. stocks?
In order to invest in Sangamo Therapeutics, Inc. (SGMO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
